← Back to UR-144

UR-144 Stats & Data

Cannabinoid

PubChem CID 44626619

NPS DataHub

MW311.47

FormulaC21H29NO

CAS1199943-44-6

IUPAC(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone

SMILESCCCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc12

InChIKeyNBMMIBNZVQFQEO-UHFFFAOYSA-N

Cannabinoids; 2020/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen; 2021/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen; 2022/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen

Chemical Class Tetramethylcyclopropanoylindole

Experience Report Analysis

Erowid

3 Reports

2012–2013 Date Range

2 With Age Data

1 Effects Detected

Demographics

Gender Distribution

Age Distribution

Reports Over Time

Effect Analysis

Erowid

Effects aggregated from 3 experience reports (3 Erowid)

3 Reports

1 Effects Detected

0 Positive

1 Adverse

0 Neutral

Effect Sentiment Distribution

Confidence Distribution

Positive Effects 0

Adverse Effects 1

Anxiety 100.0% 70%

Real-World Dose Distribution

62K Doses

From 1 individual dose entries

Form / Preparation

Most common forms and preparations reported

Read full reports on Erowid →

← Back to UR-144